Serina Therapeutics, Inc. is a drug delivery company based in
Huntsville,
Alabama,
USA. Serina is engaged in the design and optimization of novel biocompatible polymers that can impart their physicochemical properties to drug molecules to create safer, more effective medicines. This proprietary technology is the core for a business based on the discovery of new drug candidates and their development as potential clinical candidates. Serina is also working with other drug companies to apply our expertise to optimize their
drug molecules.
A large number of scientists are working on the identification of new drug candidates, and this work
is proving to be productive. Our strategy is to assist
these scientists by collaborating to produce viable drug product options that will have better clinical outcomes. Serina is committed to the highest standards in quality from early discovery to commercialization.
Serina (Sah-REE-nah)
The name comes from the word Serinus, which is the genus of several species of canaries. These birds are bold, attractive, vocal and global which is a good representation of the potential of our drug delivery polymer platforms.
